Healthcare Equipment and Supplies
Company Overview of SynCardia Systems, Inc.
SynCardia Systems, Inc., a medical technology company, focuses on developing, manufacturing, and commercializing the SynCardia temporary Total Artificial Heart (TAH-t) in the United States, European Union, and Canada. Its SynCardia TAH-t is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The company was founded in 2001 and is headquartered in Tucson, Arizona.
1992 East Silverlake Road
Tucson, AZ 85713
Founded in 2001
Key Executives for SynCardia Systems, Inc.
SynCardia Systems, Inc. Key Developments
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact SynCardia Systems, Inc., please visit www.syncardia.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.